Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Abvc Biopharma (ABVC) over the last 12 years, with Q3 2025 value amounting to 0.04.

  • Abvc Biopharma's Debt Ratio fell 6684.29% to 0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04, marking a year-over-year decrease of 6684.29%. This contributed to the annual value of 0.11 for FY2024, which is 1686.91% down from last year.
  • Latest data reveals that Abvc Biopharma reported Debt Ratio of 0.04 as of Q3 2025, which was down 6684.29% from 0.05 recorded in Q2 2025.
  • Abvc Biopharma's Debt Ratio's 5-year high stood at 0.22 during Q2 2021, with a 5-year trough of 0.03 in Q3 2021.
  • Moreover, its 5-year median value for Debt Ratio was 0.08 (2021), whereas its average is 0.09.
  • As far as peak fluctuations go, Abvc Biopharma's Debt Ratio crashed by 9050.36% in 2021, and later surged by 15952.18% in 2022.
  • Over the past 5 years, Abvc Biopharma's Debt Ratio (Quarter) stood at 0.08 in 2021, then surged by 159.52% to 0.2 in 2022, then plummeted by 32.19% to 0.13 in 2023, then fell by 16.87% to 0.11 in 2024, then crashed by 65.71% to 0.04 in 2025.
  • Its Debt Ratio stands at 0.04 for Q3 2025, versus 0.05 for Q2 2025 and 0.05 for Q1 2025.